These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3279015)

  • 1. Cephalosporinase interactions and antimicrobial activity of BMY-28142, ceftazidime and cefotaxime.
    Hiraoka M; Masuyoshi S; Mitsuhashi S; Tomatsu K; Inoue M
    J Antibiot (Tokyo); 1988 Jan; 41(1):86-93. PubMed ID: 3279015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrolytic rate at low drug concentration as a limiting factor in resistance to newer cephalosporins.
    Hiraoka M; Inoue M; Mitsuhashi S
    Rev Infect Dis; 1988; 10(4):746-51. PubMed ID: 3055173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of cefpirome and a cephalosporinase from Citrobacter freundii GN7391.
    Satake S; Hiraoka M; Mitsuhashi S
    Antimicrob Agents Chemother; 1989 Mar; 33(3):398-9. PubMed ID: 2658787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of E1040 with cephalosporinase from Citrobacter freundii GN7391.
    Inoue E; Mitsuhashi S
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2157-9. PubMed ID: 2694954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
    Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
    Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of inhibition of chromosomal beta-lactamases by third-generation cephalosporins.
    Charnas RL; Then RL
    Rev Infect Dis; 1988; 10(4):752-60. PubMed ID: 3142012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity of cephalosporins for beta-lactamases as a factor in antibacterial efficacy.
    Phelps DJ; Carlton DD; Farrell CA; Kessler RE
    Antimicrob Agents Chemother; 1986 May; 29(5):845-8. PubMed ID: 3524432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin.
    Neu HC; Chin NX; Jules K; Labthavikul P
    J Antimicrob Chemother; 1986 Apr; 17(4):441-52. PubMed ID: 3486862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative antibacterial activity of cefotaxime, ceftazidime and cefepime with regard to different strains of Enterobacter aerogenes selected for their resistance to third generation cephalosporins].
    Husson MO; Quelquejay J; Fruchart A; Izard D
    Pathol Biol (Paris); 2000 Dec; 48(10):933-9. PubMed ID: 11204925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.
    Fuchs PC; Jones RN; Barry AL; Thornsberry C
    Antimicrob Agents Chemother; 1985 May; 27(5):679-82. PubMed ID: 3893316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity of cefmenoxime for beta-lactamases: an analysis.
    Labia R; Morand A; Verchere-Beaur C; Bryskier A
    Am J Med; 1984 Dec; 77(6A):25-7. PubMed ID: 6097119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of in vitro resistance of Pseudomonas aeruginosa to cefepime, ceftazidime, and cefotaxime.
    Fung-Tomc J; Huczko E; Pearce M; Kessler RE
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1443-5. PubMed ID: 3143306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of ceftazidime and other cephalosporins to a range of beta-lactamases and their potential as inducing agents.
    Mouton RP; Bongaerts GP; van Gestel MH
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():147-52. PubMed ID: 19802978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of cefdinir with beta-lactamases.
    Labia R; Morand A
    Drugs Exp Clin Res; 1994; 20(2):43-8. PubMed ID: 7924895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrolysis of third-generation cephalosporins by class C beta-lactamases. Structures of a transition state analog of cefotoxamine in wild-type and extended spectrum enzymes.
    Nukaga M; Kumar S; Nukaga K; Pratt RF; Knox JR
    J Biol Chem; 2004 Mar; 279(10):9344-52. PubMed ID: 14660590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism.
    Then RL; Angehrn P
    Antimicrob Agents Chemother; 1982 May; 21(5):711-7. PubMed ID: 6808912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activity of T-5575, a novel 2-carboxypenam, and its stability to beta-lactamase.
    Matsumura N; Minami S; Mitsuhashi S
    J Antimicrob Chemother; 1997 Jan; 39(1):31-4. PubMed ID: 9044025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents.
    Nikaido H; Liu W; Rosenberg EY
    Antimicrob Agents Chemother; 1990 Feb; 34(2):337-42. PubMed ID: 2109581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-lactamase-mediated resistance to extended spectrum cephalosporins among clinical isolates of Pseudomonas aeruginosa.
    Ben-Mahrez K; Rejiba S; Belhadj C; Belhadj O
    Res Microbiol; 1999; 150(6):403-6. PubMed ID: 10466408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-spectrum beta-lactamase producing strains of Enterobacter cloacae transferring resistance to cefotaxime and ceftazidime.
    Blahová J; Králiková K; Krcméry V; Schäfer V
    J Chemother; 1999 Apr; 11(2):97-102. PubMed ID: 10326739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.